Fig. 2From: RAS testing practices and RAS mutation prevalence among patients with metastatic colorectal cancer: results from a Europe-wide survey of pathology centres RAS mutation prevalence by codon for tumour samples tested for all RAS codons (n = 2,245)Back to article page